Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Announces Q1 results & Limited Review Report for the Quarter ended June 30, 2015

 Cadila Healthcare Ltd has announced the following results for the quarter ended June 30, 2015 :The Un-Audited Standalone results for the Quarter ended June 30, 2015: The Company has posted a net profit of Rs. 5557.50 million for the quarter ended June 30, 2015 as compared to Rs. 1972.90 million for the quarter ended June 30, 2014. Total Income has increased from Rs. 11291.30 million for the quarter ended June 30, 2014 to Rs. 19299.30 million for the quarter ended June 30, 2015....
12-08-2015
Bigul

Zydus receives final approval for Amiloride Hcl Tablets

 Cadila Healthcare Ltd has informed BSE regarding a Press Release dated August 11, 2015 titled "Zydus receives final approval for Amiloride Hcl Tablets".
11-08-2015
Bigul

Q1 results on August 12, 2015

 Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 12, 2015, inter alia, to consider & approve the unaudited financial results for the quarter ended on June 30, 2015 (Q1).Further, as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed from August 03,...
24-07-2015
Bigul

Cut-off Date for E-voting

 Cadila Healthcare Ltd has informed BSE regarding "Cut-off Date for E-voting".
17-07-2015
Bigul

AGM on August 12, 2015

 Cadila Healthcare Ltd has informed BSE that the 20th Annual General Meeting (AGM) of the Company will be held on August 12, 2015.
16-07-2015
Bigul

Shareholding Pattern For June 30, 2015

 Cadila Healthcare Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.
07-07-2015
Bigul

Zydus receives market authorisation for Morphine Sulfate ER Tablets

 Cadila Healthcare Ltd has informed BSE regarding a Press Release dated July 01, 2015 titled "Zydus receives market authorisation for Morphine Sulfate ER Tablets".
01-07-2015
Bigul

Zydus receives final approval for Pyridostigmine Bromide Tablets

 Cadila Healthcare Ltd has submitted to BSE a copy of Press Release dated June 24, 2015 titled "Zydus receives final approval for Pyridostigmine Bromide Tablets"
24-06-2015
Bigul

Outcome of Board Meeting

 Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 15, 2015, decided to delist Equity Shares of the Company from Ahmedabad Stock Exchange Limited (ASE), in view of non-trading of Equity Shares of the Company on ASE since last so many years.Further, 20,47,48,520 Equity Shares of Rs. 5/- each fully paid-up are listed with BSE Ltd. and National Stock Exchange of India Limited having nationwide...
09-06-2015
Bigul

Zydus to present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patient With Type 2 Diabetes At American Diabetes Association 75th Scientific Sessions in Boston, USA

 Cadila Healthcare Ltd has informed BSE regarding a Press Release dated June 06, 2015 titled "Zydus to present New Scientific Data on Lipaglyn (Saroglitazar), and Real World Data in Patient With Type 2 Diabetes At American Diabetes Association 75th Scientific Sessions in Boston, USA.".
08-06-2015
Next Page
Close

Let's Open Free Demat Account